| HOME >> MEDICINE >> TECHNOLOGY |
Six-Month Results: For the six-month period ended September 30, 2011, Abaxis reported revenues of $76.0 million, as compared with revenues of $70.2 million for the comparable period last year, an increase of 8 percent.
Revenues from instrument sales increased by an aggregate of $1.3 million, or 9 percent, over the same period last year.
Revenues from consumables increased by an aggregate of $5.6 million, or 11 percent, over the same period last year.
The company reported net income of $5.5 million, compared to $7.3 million for the same period last year.
The company's effective tax rate in the six-month period ended September 30, 2011, was 37 percent, compared to 39 percent for the same period last year. The company reported diluted net income per share of $0.24 (calculated based on 22,850,000 shares) for the six-month period ended September 30, 2011, compared to $0.32 per share (calculated based on 22,736,000 shares) for the same period last year.
Other Reported Information: Total sales in the medical market for the second quarter of fiscal 2012 were $7.3 million, an increase of 7 percent, compared to the same period last year. Medical sales worldwide, excluding sales to the U.S. government, during the second quarter of fiscal 2012 were $6.3 million, an increase of 6 percent, compared to the same period last year. Total sales in the veterinary market for the second quarter of fiscal 2012 were $31.5 million, an increase of 18 percent, compared
'/>"/>
| SOURCE ABAXIS, Inc. Copyright©2010 PR Newswire. All rights reserved |